329 related articles for article (PubMed ID: 33923385)
1. Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Zeisel MB; Guerrieri F; Levrero M
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33923385
[TBL] [Abstract][Full Text] [Related]
2. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Xie Y
Adv Exp Med Biol; 2017; 1018():11-21. PubMed ID: 29052129
[TBL] [Abstract][Full Text] [Related]
4. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B x antigen (HBx) is an important therapeutic target in the pathogenesis of hepatocellular carcinoma.
Medhat A; Arzumanyan A; Feitelson MA
Oncotarget; 2021 Nov; 12(24):2421-2433. PubMed ID: 34853663
[TBL] [Abstract][Full Text] [Related]
6. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus molecular biology and pathogenesis.
Lamontagne RJ; Bagga S; Bouchard MJ
Hepatoma Res; 2016; 2():163-186. PubMed ID: 28042609
[TBL] [Abstract][Full Text] [Related]
8. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic role of hepatitis B virus.
Rivière L; Ducroux A; Buendia MA
Recent Results Cancer Res; 2014; 193():59-74. PubMed ID: 24008293
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation in chronic hepatitis B virus infection.
Dandri M
Semin Immunopathol; 2020 Apr; 42(2):173-185. PubMed ID: 32185454
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
Lamontagne J; Steel LF; Bouchard MJ
World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
[TBL] [Abstract][Full Text] [Related]
14. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.
Zhang YQ; Guo JS
World J Gastroenterol; 2015 Apr; 21(13):3860-6. PubMed ID: 25852270
[TBL] [Abstract][Full Text] [Related]
15. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
16. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.
Rapti I; Hadziyannis S
World J Hepatol; 2015 May; 7(8):1064-73. PubMed ID: 26052395
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma.
Andrisani O
Hepatoma Res; 2021; 7():. PubMed ID: 33614973
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
[TBL] [Abstract][Full Text] [Related]
20. Autophagy and microRNA in hepatitis B virus-related hepatocellular carcinoma.
Wu SY; Lan SH; Liu HS
World J Gastroenterol; 2016 Jan; 22(1):176-87. PubMed ID: 26755869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]